agilon health, inc. (AGL)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Next report
Nov 3, 2026
Expected from filing cadence
EPS target
$-1.18
Estimates not sourced
Revenue target
$1.46B
Estimates not sourced
Trailing EPS (avg 4Q)
$-3.85
Beat rate last 4: 50%
Latest EPS YoY
+116.6%
vs 2025-08-05
Latest revenue YoY
+7.2%
How results look so far
Trailing revenue (avg 4Q)
$1.48B
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS beat
EPS actual / est
$1.04 / $0.14
+622.2%
Revenue actual / est
$1.49B / $1.45B
+3.0%
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-1.18 | Pending | — | $1.46B | Pending | — |
| 8/5/2026 | $0.14 | $1.04 | +622.2% | $1.45B | $1.49B | +3.0% |
| 5/6/2026 | $1.13 | $1.80 | +59.3% | $1.38B | $1.42B | +2.9% |
| 2/25/2026 | $-6.75 | $-11.50 | -70.4% | $1.47B | $1.57B | +6.8% |
| 11/4/2025 | $-3.73 | $-6.75 | -80.7% | $1.42B | $1.44B | +1.0% |
| 8/5/2025 | $-2.75 | $-6.25 | -127.3% | $1.47B | $1.39B | -5.2% |
| 5/6/2025 | $-0.07 | $0.73 | +1082.6% | $1.50B | $1.53B | +1.9% |
| 2/25/2025 | $-0.18 | $-6.50 | -3511.1% | $1.52B | $1.52B | +0.3% |
| 11/7/2024 | $-2.50 | $-7.25 | -190.0% | $1.47B | $1.45B | -1.3% |
| 8/6/2024 | $-1.75 | $-1.75 | 0.0% | $1.54B | $1.48B | -3.8% |
| 5/7/2024 | $-0.32 | $0.25 | +179.0% | $1.61B | $1.60B | -0.6% |
| 2/27/2024 | $-0.28 | $-10.25 | -3600.4% | $1.04B | $1.06B | +1.9% |
| 11/2/2023 | $-0.30 | $-1.50 | -400.0% | $1.13B | $1.22B | +7.1% |
| 8/3/2023 | $-0.02 | $-1.00 | -5364.5% | $1.11B | $1.15B | +3.6% |
| 5/9/2023 | $0.04 | $1.00 | +2757.1% | $1.08B | $1.14B | +5.4% |
| 3/1/2023 | $-0.10 | $-3.50 | -3504.5% | $662.0M | $689.8M | +4.2% |
| 11/3/2022 | $-0.05 | $-1.75 | -3400.0% | $662.2M | $695.0M | +5.0% |
| 8/4/2022 | $-0.42 | $-1.00 | -138.8% | $647.8M | $670.1M | +3.4% |
| 5/5/2022 | $-0.00 | $0.00 | +583.3% | $642.9M | $653.4M | +1.6% |
| 3/3/2022 | $-0.11 | $-3.50 | -3081.8% | $452.9M | $462.9M | +2.2% |
Need AGL data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.